39 related articles for article (PubMed ID: 28253825)
1. Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.
Labib HA; Elantouny NG; Ibrahim NF; Alnagar AA
Hematology; 2017 Aug; 22(7):392-397. PubMed ID: 28253825
[TBL] [Abstract][Full Text] [Related]
2. Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia.
Saffari N; Rahgozar S; Faraji E; Sahin F
Sci Rep; 2024 Jan; 14(1):691. PubMed ID: 38184700
[TBL] [Abstract][Full Text] [Related]
3. Regulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia.
Tan YS; Kim M; Kingsbury TJ; Civin CI; Cheng WC
PLoS One; 2014; 9(11):e111777. PubMed ID: 25368993
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
Nabhan M; Louka ML; Khairy E; Tash F; Ali-Labib R; El-Habashy S
Gene; 2017 Sep; 628():253-258. PubMed ID: 28732737
[TBL] [Abstract][Full Text] [Related]
5. Genetic Basis of Acute Lymphoblastic Leukemia.
Iacobucci I; Mullighan CG
J Clin Oncol; 2017 Mar; 35(9):975-983. PubMed ID: 28297628
[TBL] [Abstract][Full Text] [Related]
6. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
7. Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia.
Álvarez-Zúñiga CD; Garza-Veloz I; Martínez-Rendón J; Ureño-Segura M; Delgado-Enciso I; Martinez-Fierro ML
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627214
[TBL] [Abstract][Full Text] [Related]
8. Review of molecular biological studies on acute lymphoblastic leukemia treated by modified shengmaiyin.
Guo D; Gu M; Du F; Zhao Y; Gao M; Hao J
Medicine (Baltimore); 2023 Jun; 102(23):e34013. PubMed ID: 37335634
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
Sevcikova A; Fridrichova I; Nikolaieva N; Kalinkova L; Omelka R; Martiniakova M; Ciernikova S
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174123
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.
Mendiola-Soto DK; Bárcenas-López DA; Pérez-Amado CJ; Cruz-Miranda GM; Mejía-Aranguré JM; Ramírez-Bello J; Hidalgo-Miranda A; Jiménez-Morales S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982511
[TBL] [Abstract][Full Text] [Related]
11. A microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols.
Chang YH; Jou ST; Yen CT; Lin CY; Yu CH; Chang SK; Lu MY; Chang HH; Pai CH; Hu CY; Lin KH; Lin SR; Lin DT; Chen HY; Yang YL; Lin SW; Yu SL
Am J Cancer Res; 2022; 12(10):4764-4774. PubMed ID: 36381326
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer.
Dalmizrak A; Dalmizrak O
Front Bioeng Biotechnol; 2022; 10():956563. PubMed ID: 36225602
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.
Kyriakidis I; Kyriakidis K; Tsezou A
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010971
[TBL] [Abstract][Full Text] [Related]
14. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation.
Gaál Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628648
[TBL] [Abstract][Full Text] [Related]
15. The emerging role non-coding RNAs in B cell-related disorders.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Taheri M; Jamali E
Cancer Cell Int; 2022 Feb; 22(1):91. PubMed ID: 35193592
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles in Acute Leukemia: A Mesmerizing Journey With a Focus on Transferred microRNAs.
Izadirad M; Huang Z; Jafari F; Hamidieh AA; Gharehbaghian A; Li YD; Jafari L; Chen ZS
Front Cell Dev Biol; 2021; 9():766371. PubMed ID: 34692712
[TBL] [Abstract][Full Text] [Related]
17. B-cell acute lymphoblastic leukemia-related microRNAs: uncovering their diverse and special roles.
Lv M; Zhu S; Peng H; Cheng Z; Zhang G; Wang Z
Am J Cancer Res; 2021; 11(4):1104-1120. PubMed ID: 33948348
[TBL] [Abstract][Full Text] [Related]
18. miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells.
Zhang L; Yu L; Liu Y; Wang S; Hou Z; Zhou J
Oncol Lett; 2021 Feb; 21(2):119. PubMed ID: 33376550
[TBL] [Abstract][Full Text] [Related]
19. The Expression of MicroRNA-21 in Bone Marrow Fluid is an Indicator of Hematological Disorders and Mortality.
Chang WT; Huang TL; Chen ZC; Feng YH
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2817-2821. PubMed ID: 33112535
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia.
Donzelli S; Farneti A; Marucci L; Ganci F; Sacconi A; Strano S; Sanguineti G; Blandino G
Front Cell Dev Biol; 2020; 8():257. PubMed ID: 32373612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
